Key result
This paper is a protocol for a systematic review and meta-analysis to evaluate the therapeutic effectiveness of repetitive transcranial magnetic stimulation for long COVID symptoms and contains no clinical results.
Why the study?
Long COVID lacks effective treatments, and given the expanding use of transcranial magnetic stimulation, an updated meta-analysis was needed to evaluate its efficacy.
Does repetitive Transcranial Magnetic Stimulation (rTMS) improve clinical and functional outcomes in individuals with long COVID or post-COVID syndrome?
Meta-Analysis
Does repetitive Transcranial Magnetic Stimulation (rTMS) improve clinical and functional outcomes in individuals with long COVID or post-COVID syndrome?
This protocol outlines a planned systematic review and meta-analysis to evaluate the efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) for treating long COVID symptoms.
No results yet on rTMS for long COVID; protocol leaves efficacy unresolved pending completion.
Objective To synthesise quantitative evidence on the effectiveness of Transcranial Magnetic Stimulation (TMS) as an intervention for individuals with long COVID/post-COVID syndrome. Introduction An estimated 65 million people worldwide meet the WHO’s criteria for post-COVID-19 condition, a multisystem disorder with persistent symptoms following SARS-CoV-2 infection. Despite its global impact, effective treatments are limited. A recent review highlighted early but promising results from non-invasive brain stimulation techniques, including transcranial magnetic stimulation (TMS), though the underlying mechanisms remain unclear. Given the expanding use of TMS in long COVID, a follow-up meta-analysis is needed to reflect recent developments. This review aims to evaluate the efficacy of TMS in treating post-COVID-19 symptoms. Inclusion criteria This review will include studies that investigate interventions involving TMSin individuals diagnosed with long COVID or post-COVID syndrome, limited to those published in the English language. Studies will be excluded if they do not involve rTMS as a therapeutic intervention, do not involve TMS at all, focus on populations other than those with long COVID or post-COVID condition, are review articles or case studies, or are not published in English. Methods A comprehensive search will be conducted in CINAHL Ultimate, MEDLINE, ScienceDirect, and Scopus using a strategy developed with the research team. Retrieved citations will be managed in Rayyan. Two independent reviewers will screen titles and abstracts, followed by full-text screening and data extraction by two other independent reviewers. All stages will follow predefined, pilot-tested inclusion and exclusion criteria. Discrepancies will be resolved by a third reviewer or team discussion. Intra-rater reliability at both screening stages will be assessed using Cohen’s Kappa. Study characteristics and findings will be presented using both narrative synthesis and tabular formats. Review registration https://doi.org/10.17605/OSF.IO/RE235
No takes yet. Share an insight, caveat, or question.
Sanal‐Hayes et al. (2025) conducted a meta-analysis in Long COVID / Post-COVID syndrome. Repetitive Transcranial Magnetic Stimulation (rTMS) vs. Sham TMS, standard care, or no-treatment controls was evaluated on Effectiveness of rTMS on long COVID/Post-COVID symptoms (e.g., fatigue, cognitive dysfunction, mood disturbances, quality of life). This paper is a protocol for a systematic review and meta-analysis to evaluate the therapeutic effectiveness of repetitive transcranial magnetic stimulation for long COVID symptoms and contains no clinical results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: